Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: A phase I/II trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Breast Neoplasms
  • Doxorubicin
  • Mastectomy, Modified Radical
  • Paclitaxel
  • Radiation-Sensitizing Agents

abstract

  • Twice-weekly paclitaxel with concurrent RT is a feasible and effective primary treatment for LABC. Future studies should compare primary chemoradiation to chemotherapy in LABC.

publication date

  • March 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2003.06.132

PubMed ID

  • 12610186

Additional Document Info

start page

  • 864

end page

  • 70

volume

  • 21

number

  • 5